Mumbai: Hiranandani Hospital starts Bone Marrow Transplant Unit

6 122
Inauguration of BMT unit at Hiranandani Hospital, Mumbai.

 Rohit Shishodia
Mumbai’s Dr L H Hiranandani Hospital has set up a dedicated Bone Marrow Transplant (BMT) Unit to provide infection free treatment to those who need bone marrow transplants.

The doctors at the BMT unit treat patients with blood cancers, including leukemia, lymphoma and myeloma, as well as other hematological disorders like thalassemia, aplastic anemia, sickle cell disease and inherited immune deficiency disorders.

The unit was inaugurated by Padmashree Dr Suresh H. Advani. The new BMT unit, which is known as ‘Centre for Advanced Hematology & Hemato-Oncology’ is headed by Dr Ashish V Bakshi, Director of the Hematology and Oncology Program at the hospital.

Dr Bakshi said “As the immune system of patients who undergo transplant is normally weak, they get infections very easily. They are required to be cared for in a special ward where the air is filtered to prevent infections. Patients here are nursed in this isolation unit to prevent development of any infections. All these facilities are available only in this dedicated transplant center such on the 8th floor of the hospital.”

Dr Bakshi further added “As transplant patients also need blood and platelet transfusions, a very well-equipped blood bank is an essential prerequisite. Our blood bank at the hospital is equipped with apheresis machine which helps in collecting the hematopoietic stem cells from the peripheral blood of donors.”

Bone Marrow Transplant is a life-saving procedure and is the only way to treat many patients diagnosed with a blood cancer. The procedure involves taking a patient's damaged or destroyed bone marrow stem cells and replacing them with healthy stem cells from a donor.

BMT can be autologous or allogeneic. Autologous transplants use the patient's own blood cells, while allogeneic transplants use cells from a matched donor.

The inauguration event was graced with the presence of the Hospital’s Chief Managing Trustee - Dr Niranjan Hiranandani and CEO Dr Sujit Chatterjee.


0 Comments

  1. Be first to post your comments

Your Comment

Your email address will not be published. Required fields are marked *

6+1

higlobin

Back to Top